Literature DB >> 16825052

Extreme Lateral Interbody Fusion (XLIF): a novel surgical technique for anterior lumbar interbody fusion.

Burak M Ozgur1, Henry E Aryan, Luiz Pimenta, William R Taylor.   

Abstract

BACKGROUND: Minimally disruptive approaches to the anterior lumbar spine continue to evolve in a quest to reduce approach-related morbidity. A lateral retroperitoneal, trans-psoas approach to the anterior disc space allows for complete discectomy, distraction, and interbody fusion without the need for an approach surgeon.
PURPOSE: To demonstrate the feasibility of a minimally disruptive lateral retroperitoneal approach and the advantages to patient recovery. METHODS/
RESULTS: The extreme lateral approach (Extreme Lateral Interbody Fusion [XLIF]) is described in a step-wise manner. There have been no complications thus far in the author's first 13 patients.
CONCLUSIONS: The XLIF approach allows for anterior access to the disc space without an approach surgeon or the complications of an anterior intra-abdominal procedure. Longer-term follow-up and data analysis are under way, but initial findings are encouraging.

Entities:  

Mesh:

Year:  2006        PMID: 16825052     DOI: 10.1016/j.spinee.2005.08.012

Source DB:  PubMed          Journal:  Spine J        ISSN: 1529-9430            Impact factor:   4.166


  325 in total

1.  Percutaneous posterior transdiscal oblique screw fixation with lateral interbody fusion: a radiological and cadaveric study.

Authors:  Ai-Min Wu; Wen-Fei Ni; Zhen-Xuan Shao; Xiang-Jie Kong; Nai-Feng Tian; Yi-Xing Huang; Zhong-Ke Lin; Hua-Zi Xu; Yong-Long Chi
Journal:  Eur Spine J       Date:  2014-11-13       Impact factor: 3.134

2.  Less invasive approach to degenerative lumbar deformity surgery.

Authors:  Max Aebi
Journal:  Eur Spine J       Date:  2012-03       Impact factor: 3.134

3.  Direct lateral access lumbar and thoracolumbar fusion: preliminary results.

Authors:  Pedro Berjano; Massimo Balsano; Josip Buric; Mary Petruzzi; Claudio Lamartina
Journal:  Eur Spine J       Date:  2012-03-09       Impact factor: 3.134

4.  The lumbosacral plexus: anatomic considerations for minimally invasive retroperitoneal transpsoas approach.

Authors:  Patrick Guérin; Ibrahim Obeid; Anouar Bourghli; Thibault Masquefa; Stéphane Luc; Olivier Gille; Vincent Pointillart; Jean-Marc Vital
Journal:  Surg Radiol Anat       Date:  2011-10-05       Impact factor: 1.246

Review 5.  Paradigm changes in spine surgery: evolution of minimally invasive techniques.

Authors:  Zachary A Smith; Richard G Fessler
Journal:  Nat Rev Neurol       Date:  2012-06-19       Impact factor: 42.937

6.  An MRI study of psoas major and abdominal large vessels with respect to the X/DLIF approach.

Authors:  Wan-Kun Hu; Shi-Sheng He; Shao-Cheng Zhang; Yan-Bin Liu; Ming Li; Tie-Sheng Hou; Xiao-Lu Ma; Jian Wang
Journal:  Eur Spine J       Date:  2010-10-30       Impact factor: 3.134

7.  The surgical vascular anatomy of the minimally invasive lateral lumbar interbody approach: a cadaveric and radiographic analysis.

Authors:  Mustafa Alkadhim; Carmine Zoccali; Salman Abbasifard; Mauricio J Avila; Apar S Patel; Kamran Sattarov; Christina M Walter; Ali A Baaj
Journal:  Eur Spine J       Date:  2015-10-20       Impact factor: 3.134

8.  Perioperative outcomes in minimally invasive lumbar spine surgery: A systematic review.

Authors:  Branko Skovrlj; Patrick Belton; Hekmat Zarzour; Sheeraz A Qureshi
Journal:  World J Orthop       Date:  2015-12-18

9.  Lateral lumbar interbody fusion for the correction of spondylolisthesis and adult degenerative scoliosis in high-risk patients: early radiographic results and complications.

Authors:  Brad Waddell; David Briski; Rabah Qadir; Gustavo Godoy; Allison Howard Houston; Ernest Rudman; Joseph Zavatsky
Journal:  Ochsner J       Date:  2014

10.  Femoral nerve and lumbar plexus injury after minimally invasive lateral retroperitoneal transpsoas approach: electrodiagnostic prognostic indicators and a roadmap to recovery.

Authors:  Naomi A Abel; Jacob Januszewski; Andrew C Vivas; Juan S Uribe
Journal:  Neurosurg Rev       Date:  2017-05-30       Impact factor: 3.042

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.